SEC Form 4/A · accession 0001140361-15-003044
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Henry J Fuchs
Officer — EVP, Chief Medical Officer
Period of report
May 12, 2014
Accepted (ET)
Jan 28, 2015 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2014 | F | 3,001 | $59.30 | D | 64,849 | D | |
| Common StockF1 | May 13, 2014 | S | 1,434 | $58.2274 | D | 63,415 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in colum 4 is weighted average price. the price actually receved for ranged from $57.30 to $59.00. The reporting person will provide to the isuer, any security holder of the issuer, or the SEC staff, upon rquest, information regarding the number of shares sold at each price within the range.